Does LURBINECTEDIN Cause Off label use? 69 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Off label use have been filed in association with LURBINECTEDIN (ZEPZELCA). This represents 7.1% of all adverse event reports for LURBINECTEDIN.
69
Reports of Off label use with LURBINECTEDIN
7.1%
of all LURBINECTEDIN reports
6
Deaths
10
Hospitalizations
How Dangerous Is Off label use From LURBINECTEDIN?
Of the 69 reports, 6 (8.7%) resulted in death, 10 (14.5%) required hospitalization, and 2 (2.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LURBINECTEDIN. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does LURBINECTEDIN Cause?
Death (129)
Disease progression (98)
Neutropenia (59)
Nausea (58)
Thrombocytopenia (48)
Fatigue (43)
Febrile neutropenia (39)
Vomiting (37)
Asthenia (36)
Anaemia (34)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LURBINECTEDIN Alternatives Have Lower Off label use Risk?
LURBINECTEDIN vs LUSPATERCEPT
LURBINECTEDIN vs LUSPATERCEPT-AAMT
LURBINECTEDIN vs LUTEIN
LURBINECTEDIN vs LUTETIUM LU-177
LURBINECTEDIN vs LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN